Charles Laverty Article for BioSpace

  • -
Charles Laverty Mission and ABS

Charles Laverty Article for BioSpace

Charles Laverty’s Mission With ABS

Our CEO, Charles Laverty, writes for the site BioSpace.  His mission and ours is to educate people on the possible alternative to open heart surgery.

Heart Surgery is what we are striving to save many people from.  Our medical device has already received many patents.  We have also applied for FDA approval.

Saving people from going through this very traumatic procedure and very costly procedure is our mission.

The article can be found here.


  • -
Charlie Laverty and Axcessnews

Raising Further Funds Story With Charlie Laverty by Axcessnews

Melissa Thompson of Axcessnews.com did a story with our CEO Charlie Laverty on how we are raising more funds for our company.  These funds will in turn, be life saving for a lot of people.

You can read the full article here.


  • -
Tech To Manage Heart Disease

New Tech Helps Manage Heart Disease

New Technology to Help with Health

You see a lot of people wearing pieces of technology to help them stay fit.  In staying fit, this in turn, helps people manage heart disease.

Manage Heart Disease Daily

From Fitbits and Garmins to phone apps, these are just a part of the new technology to help people.  We have created a new stent system that is helping people tremendously with their heart disease.

Our CEO, Charles Laverty, wrote about this topic for Newswire and you can find the article here.


  • -
Asian Market Strategic Move post by Charles Laverty CEO

Asian Market Sees The Potential

ABS is Making Noise in Asia

We’ve recently begun the next phase of our ongoing growth strategy that will focus on developing plans for the Asian market.  CEO Charles Laverty kicked off this next phase with his recent trip to China.  He met with both medical experts and potential investment partners. The trip was a major success.

Cardiovascular illness is the leading cause of death globally and nowhere is this more evident than in Asia. The Western world had long been considered to have the highest incidents of death from heart disease, but that’s simply no longer true.

1 Out Of 5

In China 1 out of every 5 adults has some form of cardiovascular related illness and those numbers are climbing. It’s part of the global pandemic that’s cutting far too many lives short long before their time. A combination of lifestyle changes and improved medical treatments are needed to curve this problem.

While our initial focus in Asia has been on its largest market in China, this is just phase one of our plans to actively seek partnerships in the Asian market. Cardiovascular disease is a problem that the entire region is struggling to cope with. In Japan for example, the number of people suffering from hypertension is increasing steadily.

Raising Additional Funds in the Asian Market

New approaches are necessary and ABS’s innovative stenting system is a prime example. Our method allows for the placement of stents in both the mother and daughter arteries of a bifurcating lesion at the same time. The procedure is simpler, less time consuming, and more affordable than anything being used today.

In the coming months, we expect to begin the application to the FDA and other regulatory bodies.  In turn, we’ll continue to seek out new partners in Asia and around the globe. Our CEO and board have set a goal of raising an additional $20 million in investment to fund this growth and feels like ABS has huge potential.

Charles Laverty’s trip to China may have started the ball rolling, but it is one more exciting stage in the growth of ABS. The next few months will be an opportunity to continue that momentum and seek out new opportunities.


  • -
Heart Health Month

ABS Executives Support Heart Health Month

Drawing Attention To A Global Crisis

Almost 18 million people will die in 2018 because of cardiovascular disease and related conditions. This is humanity’s greatest killer and it increasingly is becoming the number one killer of both genders in most places.

February is Heart Health Month. ABS’s CEO, Charles Laverty and co-founder and Chief Medical Officer, Dr. Mehran Khorsandi, want to encourage people to support our efforts to address this global issue.

A Global Problem Affecting All Groups

Advanced Bifurcation Systems hopes to be part of the solution. Mr. Laverty points out that heart disease is the number one killer of American women and cannot be considered a ‘male disease.’ While Dr. Khorsandi encourages people to remember the global scale of the problem.

Join us in supporting heart healthy organizations, programs and by encouraging behaviors that will help us to reign in heart disease.


  • -
Charles Laverty Mission and ABS

ABS now on Biospace

Biospace Profile

We are happy to announce that we are now profiled on Biospace.com.  This is a web space to go to for industry news and careers.

This site offers an extensive industry news and information on life sciences.  Biospace posts daily on breaking news in this field.  Which in turn keeps their followers and investors versed in the latest in the medical, pharmaceutical and biotech fields.

A Very Useful Site for the Industry

They also have career news and advice that is industry specific.  Career resources and support are also available.  You can sign up for newsletters.  Also their flagship GenePool of career and news updates that allows their feed to go directly to your inbox.

Advanced Bifurcations Systems has a career section and a profile on their site.  You can find out our latest offerings and find out more company information.

Please feel free to connect with us on any of our social media platforms.